The World Health Organisation (WHO) standard prescription for bacterial vaginosis (BV) is delivered to women across the globe on a daily basis. A group of researchers decided to test its effectiveness.
Out of 482 women aged 14-51 that visited a specific sexual health clinic over the course of a year, 74 were found to have BV (15 per cent).
Out of those 74, 11 still had BV after being twice treated with antibiotics. About half the women received a follow-up examination, and out of those, 39 per cent still had BV after treatment, leaving a big question mark over the other half of the women who never came back.
The study – Effectiveness of current therapy of bacterial vaginosis1
Treatment 1
The first treatment was 2g of oral Metronidazole in a single dose. So, pop the pill and off you go.
Treatment 2
Treatment 2 consisted of 500mg of Metronidazole twice daily by mouth for a week, or alternatively, Clindamycin twice daily at a dose of 200mg for a week.
The conclusion
The researchers concluded that standard treatments for BV are not always effective, with no significant difference noticed in the different age groups.
References
- 1.Andreeva PΜ, Omar HΑ. Effectiveness of current therapy of bacterial vaginosis. International Journal of Adolescent Medicine and Health. Published online April 2002. doi:10.1515/ijamh.2002.14.2.145
The most comprehensive vaginal microbiome test you can take at home, brought to you by world-leading vaginal microbiome scientists at Juno Bio.
Unique, comprehensive BV, AV and 'mystery bad vag' treatment guide, one-of-a-kind system, with effective, innovative treatments.
Promote and support a protective vaginal microbiome with tailored probiotic species.
